Clinical trial Recruiting at 6 sites Observational Ages 36 Months to 5

Play-based rehabilitation for children with cerebral palsy

Official title: Italian Cp eArly REhabilitation (iCARE)

Run by IRCCS Eugenio Medea · NCT06737471 · Data updated 2026-11-12

This study is testing whether different schedules of play-based rehabilitation can help children with cerebral palsy improve their skills and overall well-being.

Quick facts

Study typeObservational
Ages36 Months to 5 Years
SexAll
Enrollment96 (estimated)
SponsorIRCCS Eugenio Medea
Academic / other
Locations6 sites (Como, Como and 5 other locations)
StatusRecruiting
StartedMay 21, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2026
Registry record updatedMay 1, 2025
Trial IDNCT06737471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged between 6 months and 5 years diagnosed with cerebral palsy due to various neurological conditions.

Probably not a fit

Patients with profound deafness, severe visual impairments, neurodegenerative diseases, acquired brain injuries, or brain tumors may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of play-based rehabilitation delivered as usual care for children with cerebral palsy. It compares two formats of rehabilitation: intensive care, which consists of three daily sessions for five days a week over three weeks, and extensive care, which includes three sessions per week for 15 weeks. The aim is to determine if the delivery format impacts the rehabilitation outcomes in this population. The study is conducted in rehabilitation centers that provide both intensive and extensive care.

Why it matters

Potential benefit: If successful, this study could enhance rehabilitation strategies for children with cerebral palsy, potentially improving their motor and cognitive outcomes.

How similar studies have gone: While few studies have examined the efficacy of rehabilitation in this population, the approach of comparing intensive and extensive care formats is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age between 6 months (corrected age in case of prematurity) and 5 years;
* a diagnosis of cerebral palsy due to perinatal suffering, neurological syndromes, rare diseases with neurological impairment or congenital diseases of unknown nature.

Exclusion Criteria:

* profound deafness and/or severe hypovisus/blindness;
* a diagnosis of neurodegenerative diseases, acquired brain injury or brain tumor.

Where it's running

  • Associazione "La Nostra Famiglia" - Centro di Riabilitazione Ambulatoriale Diurno
    Como, Como, Italy
    Recruiting
  • Associazione "La Nostra Famiglia" - Centro di Riabilitazione Ambulatoriale Diurno e Residenziale
    Bosisio Parini, Lecco, Italy
    Recruiting
  • Scientific IRCCS, E. Medea
    Bosisio Parini, Lecco, Italy
    Recruiting
  • Associazione "La Nostra Famiglia" - Centro di Riabilitazione Ambulatoriale
    Sesto San Giovanni, Milano, Italy
    Recruiting
  • Associazione "La Nostra Famiglia" - Centro di Riabilitazione Ambulatoriale
    Carate Brianza, Monza E Brianza, Italy
    Recruiting
  • Associazione "La Nostra Famiglia" - Centro di Riabilitazione Ambulatoriale Diurno
    Vedano Olona, Varese, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.